MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 64 filers reported holding MEI PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $4,879,000 | -34.0% | 3,030,440 | -31.1% | 0.13% | -36.2% |
| Q3 2019 | $7,392,000 | -32.8% | 4,400,440 | 0.0% | 0.20% | -21.0% |
| Q2 2019 | $11,001,000 | -18.6% | 4,400,440 | 0.0% | 0.25% | -33.9% |
| Q1 2019 | $13,509,000 | +16.3% | 4,400,440 | 0.0% | 0.38% | -13.8% |
| Q4 2018 | $11,617,000 | – | 4,400,440 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |